Tafi | List of Frontiers open access articles

Original Research

Published on 28 Feb 2022

A Case-Control Study of the Dose-Response Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Acute Myocardial Infarction

in Cardiovascular Epidemiology and Prevention

Mengnan Zhao
Dan Zhao
Yuning Li
Xiaonan Wang
Boyu Yi
Bo Zhou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.823381

1,813 views
1 citation

Original Research

Published on 22 Feb 2021

Inside the Thrombus: Association of Hemostatic Parameters With Outcomes in Large Vessel Stroke Patients

in Stroke

Juan Marta-Enguita
Manuel Navarro-Oviedo
Roberto Muñoz
Jorge Olier-Arenas
Guillermo Zalba
Ramon Lecumberri
Maite Mendioroz
Jose A. Paramo
Carmen Roncal
Josune Orbe

Frontiers in Neurology

doi 10.3389/fneur.2021.599498

4,975 views
13 citations

Original Research

Published on 05 Jun 2025

Tissue plasminogen activator modified thromboelastography identifies fibrinolysis resistance in dogs with immune-mediated hemolytic anemia

in Comparative and Clinical Medicine

Robert Goggs
Samantha Davis
Marjory B. Brooks

Frontiers in Veterinary Science

doi 10.3389/fvets.2025.1571683

3,171 views
1 citation

Original Research

Published on 30 Apr 2025

Dogs with sepsis are more hypercoagulable and have higher fibrinolysis inhibitor activities than dogs with non-septic systemic inflammation

in Veterinary Emergency and Critical Care Medicine

Emily Hill
Yao Zhu
Marjory B. Brooks
Robert Goggs

Frontiers in Veterinary Science

doi 10.3389/fvets.2025.1559994

4,708 views

Original Research

Published on 16 Feb 2023

Increased thrombin activatable fibrinolysis inhibitor activity is associated with hypofibrinolysis in dogs with sepsis

in Veterinary Emergency and Critical Care Medicine

Katherine E. Sotos
Robert Goggs
Alyssa P. Stablein
Marjory B. Brooks

Frontiers in Veterinary Science

doi 10.3389/fvets.2023.1104602

4,070 views
10 citations

Original Research

Published on 19 Jan 2026

Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation

in Cardiovascular and Smooth Muscle Pharmacology

Helton Jose Reis
Luana Bernardes Xavier Costa
Gabriela Lopes Martins
Rita Carolina Figueiredo Duarte
Luma Clara Martins Costa
Estêvão Lanna Figueiredo
Francisco Rezende Silveira
Nathália Greco Coelho
Maria das Graças Carvalho
Luciene Bruno Vieira

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1685101

785 views

Review

Published on 28 Nov 2014

Discovery of GPCR ligands for probing signal transduction pathways

in Neuropharmacology

Andrea Tafi
Simone Brogi
Laurent Désaubry
Canan G. Nebigil

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00255

28,153 views
36 citations

Articles

A Case-Control Study of the Dose-Response Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Acute Myocardial Infarction

Inside the Thrombus: Association of Hemostatic Parameters With Outcomes in Large Vessel Stroke Patients

Tissue plasminogen activator modified thromboelastography identifies fibrinolysis resistance in dogs with immune-mediated hemolytic anemia

Dogs with sepsis are more hypercoagulable and have higher fibrinolysis inhibitor activities than dogs with non-septic systemic inflammation

Increased thrombin activatable fibrinolysis inhibitor activity is associated with hypofibrinolysis in dogs with sepsis

Rivaroxaban versus warfarin: differential effects on oxidative stress and fibrinolytic markers in atrial fibrillation

Discovery of GPCR ligands for probing signal transduction pathways